Skip to main content
. 2017 Jul 20;6(10):e1353856. doi: 10.1080/2162402X.2017.1353856

Figure 4.

Figure 4.

The expression of ILT2 ligands is dysregulated in leukemic cells from CLL patients. The figure shows the comparison of the MFI of HLA-G (A), HLA-E (B), HLA-F (C) and MHC class I (MHC-I) (D) expression between B cells from patients and controls analyzed by flow cytometry.